Results for tag: "Skin Neoplasms Drug"

The Skin Neoplasms Drug market is a subset of the larger Skin Cancer Drugs market. It is composed of drugs used to treat skin neoplasms, which are abnormal growths of cells that can be benign or malignant. These drugs are used to treat a variety of skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma. They can be administered orally, topically, or intravenously, depending on the type of cancer and the severity of the condition. The drugs are designed to target the cancer cells while minimizing damage to healthy cells. The Skin Neoplasms Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Other companies, such as Amgen, AstraZeneca, and Eli Lilly, also offer treatments for skin neoplasms. Show Less Read more